{"transactions":[{"id":736299,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:38:06.000Z","date":"2026-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.2565,"underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001104659-26-074753","document":"tm2618077-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074753/tm2618077-9_4seq1.xml","form_type":"4"}},{"id":736298,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T22:38:06.000Z","date":"2026-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5415,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a \"Company Stock Option\") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":15.15,"underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001104659-26-074753","document":"tm2618077-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074753/tm2618077-9_4seq1.xml","form_type":"4"}},{"id":736297,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T22:38:06.000Z","date":"2026-06-16","kind":"other","planned":false,"acquired":false,"shares":27936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the \"Issuer\"), Zydus Worldwide DMCC (\"Parent\"), Zara Merger Sub Inc., a wholly owned subsidiary of Parent (\"Purchaser\") and Zydus Pharmaceuticals (USA) Inc., pursuant to which Purchaser completed a tender offer (the \"Offer\") for all outstanding shares of common stock of the Issuer (\"Company Common Stock\") at a price of $23.50 per share in cash, without interest (the \"Offer Price\"), and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"), effective as of June 16, 2026 (the \"Effective Time\"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right [continues to Footnote 2]"},{"field":"shares","element":"transactionShares","label":"F2","text":"[continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a \"Company RSU\") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each outstanding Company RSU was cancelled and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-074753","document":"tm2618077-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926074753/tm2618077-9_4seq1.xml","form_type":"4"}},{"id":790000,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-06T22:02:05.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":4851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2026 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On December 26, 2025, the Issuer effected a 1-for-15 reverse stock split (the \"Reverse Stock Split\"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":27936,"source":{"system":"sec-edgar","filing":"0001104659-26-056413","document":"tm2613761-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465926056413/tm2613761-4_4seq1.xml","form_type":"4"}},{"id":1153829,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-09T22:01:01.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":81225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2025 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":81225,"derivative":{"exercise_price":0.6171,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":81225},"source":{"system":"sec-edgar","filing":"0001104659-25-046867","document":"tm2514518-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925046867/tm2514518-4_4seq1.xml","form_type":"4"}},{"id":1153828,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T22:01:01.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":53750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2025 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":346280,"source":{"system":"sec-edgar","filing":"0001104659-25-046867","document":"tm2514518-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465925046867/tm2514518-4_4seq1.xml","form_type":"4"}},{"id":1500529,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-29T00:00:58.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":81225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":81225,"derivative":{"exercise_price":1.01,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":81225},"source":{"system":"sec-edgar","filing":"0001104659-24-065699","document":"tm2415689-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924065699/tm2415689-3_4seq1.xml","form_type":"4"}},{"id":1500528,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T00:00:58.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":53750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that (1) vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting, and (2) were granted on the date of the Issuer's 2024 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":292530,"source":{"system":"sec-edgar","filing":"0001104659-24-065699","document":"tm2415689-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465924065699/tm2415689-3_4seq1.xml","form_type":"4"}},{"id":1807420,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-15T22:00:40.000Z","date":"2023-08-14","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":3.1384,"value":69044.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on August 14, 2023 at prices ranging from $3.11 to $3.26 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":238780,"source":{"system":"sec-edgar","filing":"0001104659-23-092060","document":"tm2322708-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000110465923092060/tm2322708-4_4seq1.xml","form_type":"4"}},{"id":1895198,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-12T22:35:28.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":3821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for these derivative securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options that vest in full on the first anniversary of the grant date and which were granted on the date of the Issuer's 2023 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":3821,"derivative":{"exercise_price":7.55,"expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":3821},"source":{"system":"sec-edgar","filing":"0001808665-23-000037","document":"wf-form4_168393090166231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866523000037/wf-form4_168393090166231.xml","form_type":"4"}},{"id":1895197,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T22:35:28.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":31194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date and which were granted on the date of the Issuer's 2023 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."}],"balance_after":260780,"source":{"system":"sec-edgar","filing":"0001808665-23-000037","document":"wf-form4_168393090166231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866523000037/wf-form4_168393090166231.xml","form_type":"4"}},{"id":2227487,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:18:27.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924322023146/doc4.xml","form_type":"4"}},{"id":2270479,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T23:16:46.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":22322,"price":2.3514,"value":52487.9508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2021 to cover taxes upon the May 11, 2022 vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on May 12, 2022 at prices ranging from $2.195 to $2.53 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":229586,"source":{"system":"sec-edgar","filing":"0001808665-22-000036","document":"wf-form4_165274298643886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866522000036/wf-form4_165274298643886.xml","form_type":"4"}},{"id":2279403,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-07T00:14:52.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":86286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date and which were granted on the date of the Issuer's 2022 Annual Meeting of Stockholders in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 18, 2021 the Issuer effected a 1-for-4 reverse stock split (the \"Reverse Stock Split\"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":251908,"source":{"system":"sec-edgar","filing":"0001237262-22-000001","document":"wf-form4_165188246286133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000123726222000001/wf-form4_165188246286133.xml","form_type":"4"}},{"id":2663457,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:51:56.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":96000,"derivative":{"exercise_price":1.29,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0000899243-21-024526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924321024526/doc4.xml","form_type":"4"}},{"id":2714662,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T21:26:12.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":357143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date."}],"balance_after":662489,"source":{"system":"sec-edgar","filing":"0001808665-21-000045","document":"wf-form4_162094115693414.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866521000045/wf-form4_162094115693414.xml","form_type":"4"}},{"id":3011541,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-10-07T01:30:01.000Z","date":"2020-10-06","kind":"purchase","acquired":true,"shares":5263,"price":19,"value":99997.0,"ownership":{"direct":true},"balance_after":5263,"source":{"system":"sec-edgar","filing":"0000899243-20-027698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237262/000089924320027698/doc4.xml","form_type":"4"}},{"id":3105364,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T20:32:18.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2020. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":12500,"derivative":{"exercise_price":1.15,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-20-017084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924320017084/doc4.xml","form_type":"4"}},{"id":3139348,"issuer":{"id":37706,"kind":"organization","name":"Assertio Holdings, Inc.","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T01:04:39.000Z","date":"2020-05-19","kind":"grant","acquired":true,"shares":237500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"As a result of a holding company reorganization effective May 19, 2020, Assertio Holdings, Inc., is the successor issuer to Assertio Therapeutics, Inc., pursuant to 12g-3(a) of the Exchange Act."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units that vest in full on the first anniversary of the grant date."}],"balance_after":305346,"source":{"system":"sec-edgar","filing":"0001808665-20-000009","document":"wf-form4_159010946122219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866520000009/wf-form4_159010946122219.xml","form_type":"4"}},{"id":3479992,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-24T21:17:51.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 19, 2019. The shares underlying the option are scheduled to vest in equal annual installments over three years from June 19, 2019."}],"balance_after":25000,"derivative":{"exercise_price":0.86,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-017965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000089924319017965/doc4.xml","form_type":"4"}},{"id":3496927,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-07T16:32:09.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 6, 2019 and vests in full on June 6, 2020, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":75000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-19-034557","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465919034557/a4.xml","form_type":"4"}},{"id":3534003,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T22:26:24.000Z","date":"2019-05-09","kind":"sale","acquired":false,"shares":12500,"price":4.6959,"value":58698.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on May 9, 2019 at prices ranging from $4.50 to $4.90 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":67846,"source":{"system":"sec-edgar","filing":"0001005201-19-000080","document":"wf-form4_155744076923920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000080/wf-form4_155744076923920.xml","form_type":"4"}},{"id":3533995,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-09T15:30:05.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2019-05-08","expiration_date":"2019-05-08","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001005201-19-000076","document":"wf-form4_155741579027885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000076/wf-form4_155741579027885.xml","form_type":"4"}},{"id":3533994,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T15:30:05.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80346,"source":{"system":"sec-edgar","filing":"0001005201-19-000076","document":"wf-form4_155741579027885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000076/wf-form4_155741579027885.xml","form_type":"4"}},{"id":3533993,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-09T15:30:05.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":39584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units that vest in full on the first anniversary of the grant date."}],"balance_after":49096,"source":{"system":"sec-edgar","filing":"0001005201-19-000076","document":"wf-form4_155741579027885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000076/wf-form4_155741579027885.xml","form_type":"4"}},{"id":3657705,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-02-14T21:19:36.000Z","date":"2018-05-15","kind":"exercise","acquired":false,"shares":19512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-05-15","expiration_date":"2018-05-15","underlying":"Common Stock","underlying_shares":19512},"source":{"system":"sec-edgar","filing":"0001005201-19-000020","document":"wf-form5_155017916193096.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000020/wf-form5_155017916193096.xml","form_type":"5"}},{"id":3657704,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-14T21:19:36.000Z","date":"2018-05-15","kind":"exercise","acquired":true,"shares":19512,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9512,"source":{"system":"sec-edgar","filing":"0001005201-19-000020","document":"wf-form5_155017916193096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520119000020/wf-form5_155017916193096.xml","form_type":"5"}},{"id":3729789,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-17T15:53:12.000Z","date":"2018-12-14","kind":"sale","acquired":false,"shares":10000,"price":4.0693,"value":40693.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on December 14, 2018 at prices ranging from $3.99 to $4.16 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price."}],"balance_after":9512,"source":{"system":"sec-edgar","filing":"0001005201-18-000027","document":"wf-form4_154506197647847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000100520118000027/wf-form4_154506197647847.xml","form_type":"4"}},{"id":3899781,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-08T17:03:17.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-18-039223","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039223/a4.xml","form_type":"4"}},{"id":3899780,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T17:03:17.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 7, 2018 and vests in full on June 7, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":50000,"derivative":{"exercise_price":0.6,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-18-039223","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039223/a4.xml","form_type":"4"}},{"id":3899779,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T17:03:17.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":17949,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":17949,"source":{"system":"sec-edgar","filing":"0001104659-18-039223","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039223/a4.xml","form_type":"4"}},{"id":3939631,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-11T00:07:46.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 08, 2019, assuming continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 08, 2019, assuming continued service through the applicable vesting date."}],"balance_after":31250,"derivative":{"underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001179110-18-006587","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911018006587/edgar.xml","form_type":"4"}},{"id":4232990,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-08-16T22:41:57.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":19512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock unit awards pursuant to the Company's Non-Employee Director Compensation and Grant Policy."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 15, 2018, assuming continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are scheduled to vest on May 15, 2018, assuming continued service through the applicable vesting date."}],"balance_after":19512,"derivative":{"underlying":"Common Stock","underlying_shares":19512},"source":{"system":"sec-edgar","filing":"0001179110-17-011572","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017011572/edgar.xml","form_type":"4"}},{"id":4286851,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T17:04:45.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":17949,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-17-038465","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465917038465/a4.xml","form_type":"4"}},{"id":4286850,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-09T17:04:45.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 8, 2017 and vests in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":14000,"derivative":{"exercise_price":3.9,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-17-038465","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465917038465/a4.xml","form_type":"4"}},{"id":4368591,"issuer":{"id":149352,"kind":"organization","name":"Assertio Therapeutics, Inc","symbol":"ASRT"},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-03-30T20:22:41.000Z","date":"2017-03-28","kind":"grant","acquired":true,"shares":29268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options are exercisable in 36 equal monthly installments."}],"balance_after":29268,"derivative":{"exercise_price":14.23,"expiration_date":"2027-03-28","underlying":"Common Stock","underlying_shares":29268},"source":{"system":"sec-edgar","filing":"0001179110-17-005249","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005201/000117911017005249/edgar.xml","form_type":"4"}},{"id":4498286,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T21:22:34.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":1948,"price":0.77,"value":1499.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Consists of shares of common stock issued in lieu of cash retainers for board and committee service in accordance with an election of the reporting person under the company's non-employee director compensation program. The number of shares is equal to the amount of the cash retainers that would otherwise have been payable to the reporting person for the fourth fiscal quarter of 2016 divided by $0.77, the closing price of the company's common stock on the NASDAQ Global Market on January 3, 2017."}],"balance_after":3418,"source":{"system":"sec-edgar","filing":"0001209191-17-002074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919117002074/doc4.xml","form_type":"4"}},{"id":4576858,"issuer":{"id":7799,"kind":"organization","name":"Dare Bioscience, Inc."},"owners":[{"id":37714,"kind":"person","name":"MCKEE WILLIAM","position":1,"cik":"0001237262","reported_name":"MCKEE WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-20T22:59:18.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":1470,"price":1.02,"value":1499.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issued in lieu of cash retainers for board and committee service in accordance with an election of the reporting person under the company's non-employee director compensation program.  The number of shares is equal to the amount of the cash retainers that would otherwise have been payable to the reporting person for the third fiscal quarter of 2016 divided by $1.02, the closing price of the company's common stock on the NASDAQ Global Market on October 3, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Consists of shares of common stock issued in lieu of cash retainers for board and committee service in accordance with an election of the reporting person under the company's non-employee director compensation program.  The number of shares is equal to the amount of the cash retainers that would otherwise have been payable to the reporting person for the third fiscal quarter of 2016 divided by $1.02, the closing price of the company's common stock on the NASDAQ Global Market on October 3, 2016."}],"balance_after":1470,"source":{"system":"sec-edgar","filing":"0001209191-16-146521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401914/000120919116146521/doc4.xml","form_type":"4"}}]}